$4.20
0.010000.24%
Pre-Market: Dec 13, 4:02 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Biodexa Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.